STEGAGNO, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 1.438
EU - Europa 544
AS - Asia 209
SA - Sud America 9
AF - Africa 6
Totale 2.206
Nazione #
US - Stati Uniti d'America 1.432
UA - Ucraina 179
IT - Italia 157
SE - Svezia 104
IN - India 82
SG - Singapore 75
CN - Cina 47
FI - Finlandia 46
GB - Regno Unito 16
DE - Germania 11
BE - Belgio 8
AR - Argentina 6
IE - Irlanda 6
BG - Bulgaria 5
CA - Canada 5
RO - Romania 5
TG - Togo 4
BR - Brasile 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
HK - Hong Kong 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
FR - Francia 1
MX - Messico 1
NL - Olanda 1
RU - Federazione Russa 1
UZ - Uzbekistan 1
Totale 2.206
Città #
Woodbridge 191
Fairfield 177
Ann Arbor 139
Houston 93
Seattle 82
Chandler 81
Jacksonville 76
Ashburn 65
Cambridge 57
Wilmington 56
Singapore 47
Princeton 45
San Paolo di Civitate 44
Plano 43
Boston 34
Beijing 33
Rome 28
Lawrence 26
San Diego 18
Andover 12
Millbury 10
Milan 9
Brussels 8
Dearborn 7
Dublin 6
Federal 6
Boardman 5
Santa Clara 5
Sofia 5
Helsinki 4
Lomé 4
Marigliano 4
Norwalk 4
Brembate di Sopra 3
Bühl 3
Des Moines 3
Nanjing 3
San Mateo 3
Toronto 3
Auburn Hills 2
Aversa 2
Brescia 2
Falls Church 2
Hong Kong 2
Indiana 2
Itanagra 2
Los Angeles 2
Mannheim 2
Mondragone 2
Nanchang 2
Naples 2
Parma 2
Prague 2
Taormina 2
Adelfia 1
Baku 1
Bari 1
Bern 1
Bitterfeld 1
Buffalo 1
Capri 1
Chaoyang 1
Chengdu 1
Chongqing 1
Cranston 1
Dubai 1
Frankfurt am Main 1
Gandhi Nagar 1
Giussano 1
Grafing 1
Guangzhou 1
Gurgaon 1
Hefei 1
La Paz 1
Las Vegas 1
Laurel 1
London 1
Marano di Napoli 1
Marche 1
Melzo 1
Mexico City 1
Minsk 1
Montréal 1
New York 1
Odessa 1
Ottawa 1
Paris 1
Perugia 1
Phoenix 1
Ponte San Pietro 1
Provo 1
Redwood City 1
Rogliano 1
San Jose 1
Sandston 1
Schio 1
Shaoxing 1
Shenyang 1
Siracusa 1
Spotorno 1
Totale 1.518
Nome #
Caratterizzazione molecolare di pazienti italiani affetti da Atassia con Aprassia Oculomotoria di tipo 1 (AOA1) 129
Clinical delineation of fetal alcohol spectrum disorders (FASD) in Italian children: Comparison and contrast with other racial/ethnic groups and implications for diagnosis and prevention 115
Levels and patterns of HIV RNA viral load in untreated pregnant women 109
Clonal dominance among T-lymphocyte infiltrates in arthritis. 98
A rapid method for the separation of functional lymphoid cell populations of human and animal origin on PVP-silica (Percoll) density gradients. 85
CONGENITAL NEUTROPENIA - SUSTAINED MYELOID CELL-PROLIFERATION AND NEUTROPHIL DIFFERENTIATION INVITRO 76
T lymphocytes in synovia of patients with rheumatoid arthritis. 71
ANTIBODY-PRODUCTION IN INFANTS BORN TO HIV-1-INFECTED MOTHERS 71
Anonymous HIV testing on newborns. 65
POOLING OF PAPER-ADSORBED BLOOD-SAMPLES TO REDUCE THE COST OF ANTI-HIV TESTING IN EPIDEMIOLOGIC STUDIES 64
Maternal and perinatal outcomes in spontaneous versus assisted conception twin pregnancies 64
Blood transfusion therapy in the newborn. 63
ANTIBODY-MEDIATED PERINATAL CYTOPENIAS 63
Temporal and geographical trends of anti-HIV-1 antibodies screening among newborns in Italy, 1990-1993 60
Diffusing capacity for carbon monoxide in children with type 1 diabetes 57
Interleukin 6 in neonates with early and late onset infection 57
Metabolic findings in a patient with adenosine deaminase deficiency and severe combined immunodeficiency. 53
Procalcitonin as a marker of late-onset neonatal infection 52
Characterization of murine newborn inhibitory T lymphocytes: functional and phenotypic comparison with an adult T cell subset activated in vitro by alphafetoprotein. 52
TERAPIA TRASFUSIONALE 51
Detection of specific IgG antibody production in vivo in infants with congenital HIV, parvovirus B19 or Toxoplasma gondii infection. 46
Functional analysis of T cell subsets and clones in human renal allograft rejection. 45
PRENATAL EXCLUSION OF PURINE NUCLEOSIDE PHOSPHORYLASE-DEFICIENCY 44
Duration of ruptured membranes and vertical transmission of HIV 1; a meta-analysis from 15 prospectives cohort studies. 44
TERAPIA TRASFUSIONALE. 43
Infezione da virus della immunodeficienza umana e AIDS 43
THE MODE OF DELIVERY AND THE RISK OF VERTICAL TRASMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1. 42
MATERNAL VIRAL LOAD AND VERTICAL TRASMISSION OF HIV 1; AN IMPORTANT FACTOR BUT NOT THE ONLY ONE. 40
INFEZIONE DA VIRUS DELL' IMMUNODEFICIENZA UMANA. 39
Anti-HIV 1 antibodies prevalence in parturients through newborn testing: results of the Italian anonymous serosurvey. The Italian Collaborative Study Group of HIV Prevalence in Newborns. 39
Descrizione di un nuovo caso di deficit di PNP 39
Effect of a brief storage on reproducibility of EBC pH measurements in samples from children with chronic respiratory symptoms 37
T lymphocyte infiltrates in inflammatory synovia are oligoclonal. 36
Prolonged reticulocytopenia and transient erythroid hypoplasia in a child with autoimmune haemolytic anaemia. 34
BLIND SEROSURVEY OF HIV ANTIBODIES IN NEWBORNS IN 92 ITALIAN HOSPITALS - A METHOD FOR MONITORING THE INFECTION-RATE IN WOMEN AT TIME OF DELIVERY 34
Immunologic follow-up of infants treated with granulocyte transfusion for neonatal sepsis. 30
Reference ranges for procalcitonin levels in neonates during the first 48 hours of life 28
Potentials and limitations of viscometry in hermorheological studies 27
Utilità della storia clinica e di uno score clinico nella diagnosi della sindrome delle apnee ostruttive nel sonno (OSAS) in età pediatrica. 27
Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically Ill neonates 26
Study of Population of Triplet Pregnacies: Maternal and Neonatl Outcomes 26
Procalcitonina e sepsi neonatale 18
L'impiego di immunoglobuline per via endovenosa (IVIG) nella sepsi del neonato 18
Totale 2.260
Categoria #
all - tutte 6.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020313 0 0 0 0 31 53 43 61 35 49 29 12
2020/2021200 29 34 5 17 12 22 1 20 15 23 20 2
2021/2022412 1 25 31 28 55 15 2 46 26 38 57 88
2022/2023385 77 93 25 24 38 45 4 21 38 2 13 5
2023/2024174 13 24 13 23 11 5 15 4 3 23 19 21
2024/202573 12 11 35 3 12 0 0 0 0 0 0 0
Totale 2.260